Wed, 05/29/2024 - 19:09 Gizmodo As Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and weight loss drugs, healthcare companies are introducing supply trackers to help patients navigate ongoing shortages.Read more... Tags eli lilly and company, anti obesity medication, health medical pharma, ro, Eli Lilly, patrik jonsson, glp1 poly agonist peptides, zepbound, zachariah reitano, eli lilly and, peptide therapeutics, Novo Nordisk, nordisk, amycretin, glp 1 Source Supplies of Wegovy and Other Weight Loss Drugs Can Now Be Tracked by Patients
